← Back to Clinical Trials
RecruitingNCT06573749

Effect of 12-week Milk Fat Globule Membrane Supplementation on the Human Muscle Function of Healthy, Recreationally Active Adults

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

ConditionAgeing Well
SponsorLoughborough University
Study TypeINTERVENTIONAL
PhaseN/A
Enrollment96
SexALL
Min Age18 Years
Max Age75 Years
Start Date2025-03-28
Completion2026-01
Interventions
Bioactive whey protein concentrateWhey protein isolate supplement

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The main aim of this study is to understand if chronic supplementation (12 weeks) of a milk fat globule membrane containing supplement, called bioactive whey protein concentrate, improves human muscle function greater than a placebo supplement within a cohort of healthy, recreationally active adults. Furthermore, we aim to investigate whether any potential benefits of milk fat globule membrane are influenced by age through the assessment of 2 distinct age subgroups (young and older). We hypothesise that neuromuscular function (strength and power) will increase from pre to post within the group that consumes bioactive whey protein concentrate but not the placebo group, with a greater increase in the older group compared to the young group.

Eligibility Criteria

Inclusion Criteria: * 18-30 or 60-75 years old * Male or female * Healthy with no contraindications to exercise * Classified as recreationally active (meet the government's guidelines for weekly physical activity - 150 minutes of moderate physical activity or 75 minutes of vigorous physical activity) Exclusion Criteria: * Any injury, medical condition or symptom precluding the ability to complete strenuous exercise as identified by the health screen questionnaire and physical activity readiness questionnaire * Uncontrolled hypertension (blood pressure of 140/90 mmHg or higher) as identified by recording resting blood pressure * Neuromuscular or musculoskeletal disease * Occurrence of a severe injury to the lower limbs or back within the previous 6 months (time loss of \> 21 days of normal activity) * Occurrence of a minor injury to the lower limbs or back within the previous month (time loss of \>1 day of normal activity) * Do not meet the government guidelines of minimum weekly physic

Related Trials